The AUS LABS PEPTIDE GROWTH STACK is a combination of our most effective peptides. This stack contains:
- 3 x Growth Pep (CJC-1925)
- 3 X Release-2 (GHRP-2)
- 12 Insulin Syringes (1ml).
- 10ml Water for Injection
GROWTH PEP (CJC-1295 DAC) is an injectable peptide used to increase GH production. This peptide is a growth hormone releasing hormone (GHRH) mimetic, or analog. That is to say, it works in the same way as GHRH, and may be referred to as being a GHRH.
The principal use of GROWTH PEP (CJC-1295 DAC) is to provide increased GH levels, which also results in increased IGF-1 levels. An increase in these levels can aid fat loss and in some instances can aid muscle gain as well. Generally, a product in the GHRH category, including GROWTH PEP (CJC-1295 DAC), is chosen as an alternate to using HGH, and only rarely is combined with HGH.
GROWTH PEP (CJC-1295 DAC) is in the class of growth hormone releasing hormone (GHRH) mimetics. GHRH is also the name of the naturally-occurring hormone in the body, but the natural compound is not used in bodybuilding or as a performance-enhancing drug due to its high cost of manufacture and its extremely brief duration of action. RELEASE (CJC-1295 DAC) is a modified version of the first 29 amino acids of GHRH, together with addition of a “Drug Affinity Complex” or DAC. The combination of modifications provides a half life of about 1 week, and steady blood levels after injection.
GROWTH PEP (CJC-1295 DAC) amplifies GH production in the same way that GHRH does. Administration does not initiate a pulse of GH release. Because GROWTH PEP (CJC-1295 DAC) provides steady blood levels, it increases the amplitude of natural GH pulses on an ongoing basis. It does not combine especially efficiently with a GHRP, because the DAC modification results in relatively lower ongoing levels of free peptide
RELEASE (GHRP-2) is an injectable peptide in the category of growth hormone releasing peptides, or GHRP’s. The most common use of these peptides is to increase GH production. Other peptides in this category include RELASE-6 (GHRP-6), hexarelin, and ipamorelin. With regard to increasing GH, all of these work similarly, and there is no need or advantage to combining them. Instead, the one most suited for the particular case is chosen. RELEASE-2 (GHRP-2) and all GHRP’s are mimetics of ghrelin, a hormone produced by cells of the stomach in response to a fasted condition, including brief fasts. Ghrelin and ghrelin mimetics work by activating the ghrelin receptor, also called the growth hormone secretagogue receptor (GHS-R1a). Elevated ghrelin levels act towards increasing GH levels by stimulation of ghrelin receptors in the pituitary.
Injection of RELEASE-2 (GHRP-2) or any GHRP stimulates GH release in essentially the same way as fasting-induced elevation of ghrelin levels. The effect can be markedly greater, however. Supraphysiological levels of GH are easily achieved with proper dosing of any GHRP.
The principal use of RELEASE-2 (GHRP-2) is to provide increased GH levels, which also results in increased IGF-1 levels. This aids fat loss and in some instances aids muscle gain as well. Generally, GHRP use is chosen as an alternate to HGH use, and only rarely is combined with HGH.
Dosage & Use:
ALL REFERENCES OF USE ARE FOR RESEARCH SUBJECTS AND NOT HUMANS
GROWTH PEP (CJC 1295) is sold in vials containing 2mg of lyophylized powder, though the amount can vary. The contents should be reconstituted by adding a convenient amount of sterile or bacteriostatic water. If for example 2 mL is chosen and the dosing of the vial is 2 mg, the resulting solution then has a concentration of 1 mg/mL, or 1000 mcg/mL.
At time of dosing, an insulin syringe is used to draw and then inject the desired amount. In the above example, a 1000 mcg dose would require a volume of 1 mL, or “100 IU” as marked on an insulin syringe.
Injection may be subcutaneous, intramuscular, or intravenous according to personal preference. If desired, peptide solutions from other vials, such as a vial of a GHRP product, may also be drawn into the same syringe, if there is room. This reduces the total number of injections required.
When recommending GROWTH PEP (CJC 1295 DAC), we recommend a dosage of 1000 mcg at a time, twice per week.
RELEASE-2 (GHRP-2) is sold in small vials of 5 mg, which should be stored under refrigeration. (It is acceptable however for them to be mailed unrefrigerated.) The vial is diluted with a convenient volume of sterile or bacteriostatic water. For example, the vial might be diluted with 2.5 mL of water, yielding a solution of 2 mg/mL (2000 mcg/mL.) After the water addition, the vial again will be stored under refrigeration.
When dosing, an appropriate volume will be drawn from the vial with (typically) an insulin syringe, according to the desired dose and the concentration of the preparation. In the above example, a 100 mcg dose would require only 0.05 mL, or “5 IU” as marked on an insulin syringe. A 300 mcg would require 0.15 mL, or “15 IU” as marked on an insulin syringe.
Injection may be subcutaneous, intramuscular, or intravenous according to personal preference.
Dosing will ordinarily be at least twice per day and preferably 3x/day for best effect, taken at least 30-60 minutes before a meal and at a time of non-elevated blood sugar (in other words, after blood sugar has had time to fall since the most recent meal.) The amount taken generally will be from 50-300 mcg at a time.
For increase in GH levels, higher doses within the suggested range definitely increase effect. With regard to healing benefit, for example for tendonitis, the low end of the range is often entirely sufficient and noticeably greater effect is not necessarily seen with increased dose.
While there is no sharp cut-off between a solution of RELEASE-2 (GHRP-2) still being good and having lost potency with time, as a general guideline, a vial should be used within a month of having been reconstituted. Past this, I would discard the vial and start a new one.
Below -20 degrees or the freezer for extended storage. Once reconstituted <8 degrees is acceptable.